Saoussen Chouchene

Saoussen Chouchene is affiliated with the University of Monastir. Her research contributions include work at the intersection of pharmacogenetics and cardiovascular medicine, with a focus on personalized therapeutic strategies for patients with complex comorbidities. Her most-cited publication, "Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?" (2018), addresses the clinical relevance of genetic testing to optimize antiplatelet therapy in high-risk populations. This work reflects her interest in translating pharmacogenomic insights into evidence-based clinical practice.

1. Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?
2. Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs Metabolism.
3. Does Lipid Profile Affect Thrombin Generation During Ramadan Fasting in Patients With Cardiovascular Risks?
4. [Hematologic abnormalities in infantile visceral leishmaniasis]
5. Platelet satellitism during cutaneous leishmaniasis.
6. Chediak-Higashi syndrome: A case report and literature review.
7. Systemic lupus erythematosus in the elderly.
8. Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes.